The Michigan Diabetes Research Center (MDRC) is a multidisciplinary unit of the University of Michigan funded by the National Institute of Diabetes and Digestive and Kidney Diseases/National Institute of Health.
The prevalence of diabetes mellitus in the United States has reached epidemic proportions and accounts for a huge national burden of morbidity, mortality, and health care expenditures. The Michigan Diabetes Research Center (MDRC) builds on the 35-year experience of the Michigan Diabetes Research and Training Center (MDRTC) as a key component of the research effort to promote new discoveries and enhance scientific progress through support of cutting-edge basic and clinical research related to the etiology and complications of diabetes. The MDRC has expanded beyond the traditional MDRC research base at the University of Michigan (UM) to include members engaged in diabetes-related research at three nearby Regional Partner Institutions, Michigan State University (MSU), Wayne State University (WSU) and the University of Toledo (UT).
The goal of the MDRC is to establish, promote, and enhance multidisciplinary and collaborative basic biomedical and clinical research among member investigators studying diabetes, its complications, and related endocrine and metabolic disorders. The missions of the MDRC are to create an environment that supports important and innovative research; raise awareness and interest in fundamental and clinical diabetes research; enhance diabetes research education and training opportunities for patients, students, scientists, and clinicians; attract and retain early stage investigators and investigators new to diabetes research; provide core services that leverage funding and unique expertise; foster interdisciplinary collaborations, especially in the emerging areas of research, to catalyze new ideas and scientific approaches; and promote the translation of scientific discoveries from bench to bedside to community to improve public health.
The MCDTR is a multidisciplinary unit of the University of Michigan funded by the National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health. The MCDTR is one of seven NIH Centers funded to focus on type 2 translational research in diabetes (e.g. bedside to practice and the community). Its goal is to facilitate innovative adaptations of evidence-based approaches to prevent and treat diabetes that can be disseminated and sustained in clinical practice and in settings outside the traditional academic research environment. The mission of the MCDTR is to establish, promote, and enhance multidisciplinary collaboration among researchers directed at the prevention and control of diabetes, its complications, and comorbidities, by providing access to specialized expertise and resources. Our research investigators are our most important resource.
The MCDTR focuses on research to better translate interventions that have clearly demonstrated efficacy into real-world populations, health care settings, and communities. The MCDTR helps to ensure that new research findings actually reach the patients and populations for whom they are intended, and that they are implemented correctly. The MCDTR seeks to improve the quality of care by helping patients and clinicians alter behaviors and make more informed choices. By empowering the patient, strengthening the patient-clinician relationship, providing reminders and point-of-care decision support tools, and reorganizing and coordinating systems of care, more effective prevention and treatment of diabetes can be achieved.